COVID-19 and it’s naysayers are attacking Science and Reason. The defenders must suffer the slings and arrows from…
On Apr. 14, 2021, the Mayo Clinic announced a new technology platform initiative to deliver the next generation…
On Mar. 2, 2021, Merck announced multiple agreements to support efforts to expand manufacturing capacity and supply of…
On Dec. 4, 2020, Novo Nordisk announced that the FDA approved an updated label for Saxenda (liraglutide) injection…
On Dec. 2, 2020, the University of Oregon opened the Phil and Penny Knight Campus for Accelerating Scientific…
On Nov. 4, 2020, using the cutting-edge genetic editing technique known as CRISP ‘lab on a chip’ technology,…
On Nov. 3, 2020, Medigen Vaccine Biologics (MVC) and the National Institute of Hygiene and Epidemiology (NIHE), a…
On Oct. 8, 2020, the La Jolla Institute for Immunology (LJI) announced it had been granted $1.4 million…
On Oct. 5, 2020, the Nobel Prize in Medicine 2020 was awarded to Harvey J. Alter, Michael Houghton…
On Sept. 23, 2020, Pascal Biosciences announced the Company had confirmed an earlier report that certain cannabinoids block…
On Sept. 14, 2020, Pascal Biosciences and SoRSE Technology announced they had entered into a collaborative research agreement…
On Sept. 8, 2020, a new collaboration between the California Institute for Regenerative Medicine (CIRM) and the Chan…
On Aug. 20, 2020, the La Jolla Institute for Immunology (LJI) announced that Erica Ollmann Saphire, Ph.D. had…
On Aug. 11, 2020, Gilead Sciences announced that the China National Medical Products Administration (NMPA) had approved a…
On Jul. 23, 2020, Dynavax Technologies and Medigen Vaccine Biologics (MVC) announced a collaboration to develop an adjuvanted…
On Jul. 14, 2020, Pascal Biosciences announced it had discovered certain cannabinoids that block replication of SARS-CoV-2, the…
On Jul. 10, 2020, the Imaging Platform at the Broad Institute of MIT and Harvard, together with industry…
On Jun. 11, 2020, Bristol-Myers Squibb announced that Opdivo (nivolumab) was approved by the FDA for the treatment…
On May 19, 2020, Phlow, a U.S.-based, public benefit drug manufacturing corporation, received federal government funding of $354…
On May 6, 2020, Mesoblast announced that the first patients were dosed in the 300-patient randomized placebo-controlled Phase…
On Apr. 30, 2020, Mesoblast announced a Phase 2/3 randomized, placebo-controlled trial to rigorously confirm whether its allogeneic…
On Apr. 28, 2020, Secarna Pharmaceuticals announced the company has entered into a cooperation with the First Affiliated…
On Apr. 24, 2020, Mesoblast announced an 83% survival in ventilator-dependent COVID-19 patients (10/12) with moderate/severe acute respiratory…
On Apr. 21, 2020, to fight the novel coronavirus pandemic, Cleveland Clinic and SAS announced they had created…
On Apr. 15, 2020, the Bill & Melinda Gates Foundation announced an expansion of its funding for the…
On Apr. 14, 2020, scientists at deCODE genetics and Iceland’s Directorate of Health and the National University Hospital…
On Apr. 10, 2020, the U.S. Department of Veterans Affairs (VA) established the VA History Office (VAHO) to…
On Apr. 10, 2020, Gilead Sciences announced results from a cohort analysis of 53 patients hospitalized with severe…
On Apr. 9, 2020, FUJIFILM announced initiation of a U.S. phase II clinical trial to evaluate the safety…
On Apr. 8, 2020, Chugai Pharma announced that it is working to start a phase III clinical trial…